DocketNumber: D075217
Citation Numbers: 251 Cal. Rptr. 3d 823, 39 Cal. App. 5th 530
Judges: Huffman
Filed Date: 8/29/2019
Status: Precedential
Modified Date: 10/19/2024
California Appellate Law Group, Anna-Rose Mathieson, Susan Horst; Behmer & Blackford, Timothy S. Blackford; Williams & Connolly, John E. Schmidtlein and Carl R. Metz, for Real Party in Interest.
*533Quidel Corporation (Quidel) has petitioned for a writ of mandate and/or prohibition directing the trial court to vacate its order granting summary adjudication. Quidel contends the trial court incorrectly concluded a provision in its contract with Beckman Coulter, Inc. (Beckman) was an invalid restraint on trade in violation of Business and Professions Code,
In 1996, Biosite Inc. (Biosite)
By 2003, Beckman had developed a laboratory analyzer, but it did not have a license for a BNP assay compatible with its analyzer. Around this same time, other companies were also pursuing BNP assays for use with their larger analyzers, which could run multiple, different immunoassays at higher volumes than the point-of-care analyzer Biosite had. One company was also developing an assay to detect NT-proBNP, a closely-related assay that is a potential direct substitute for the BNP assay and is also based on B-protein.
If Biosite were to correlate a new BNP assay for use with the Beckman lab analyzer to its Federal Drug Administration-approved BNP assay, it could avoid the need to establish the new assay's efficacy through extensive clinical trials. Collaborating would mean Biosite could expand its customer base to those who wanted to use the larger capacity laboratory analyzers and Beckman could include the BNP assay in its menu of immunoassay offerings.
Biosite and Beckman, each represented by legal counsel, negotiated the Agreement over several months, and they exchanged numerous drafts before executing it on June 24, 2003. Under the terms of the Agreement, Beckman manufactured the BNP assay for Biosite using proprietary materials that Biosite provided, including the antibodies Biosite had developed. In exchange, Biosite purchased its requirements of the BNP assay from Beckman. The Agreement prohibited Biosite from engaging other manufacturers to *535provide the BNP assay for their competing lab analyzers. The term of the Agreement was negotiated to coincide with the term of a related licensing agreement Biosite had with Scios.
Section 5.2.1 of the Agreement requires Beckman to offer for sale and to sell the BNP assay exclusively to Biosite. Section 5.2.2 prohibits Biosite from engaging third parties other than Beckman to manufacture for Biosite a diagnostic BNP assay for use. Section 5.2.3 of the Agreement prohibits Beckman from researching or developing an assay that detects the presence or absence of the BNP or NT-proBNP proteins or markers for use in diagnosing cardiac disease until two years before the Agreement's expiration. It does not prohibit the research or development of assays that detect the presence or absence of other proteins or markers, including the biomarkers ST2 or Galectin 3.
Although Beckman did not dispute that BNP and NT-proBNP assays were seen as and have become potential substitutes for purposes of the motion for summary adjudication, the parties' characterization of the BNP assays and NT-proBNP assays are slightly different. Quidel characterizes the two as closely-related, with the NT-proBNP assay serving as a potential direct substitute for the BNP assay because it detects a peptide that is secreted alongside *826the BNP. Beckman has alleged the NT-proBNP assay measures a different protein and uses different antibodies and proteins than the BNP assay, suggesting they are distinctly different.
PROCEDURAL HISTORY
On November 27, 2017, Beckman sued Quidel for declaratory relief for violation of section 16600 and violation of the Cartwright Act (§ 16720 et seq.). Beckman asked the court to issue a declaratory judgment that section 5.2.3 of the Agreement was void and unenforceable as a violation of Business and Professions Code section 16600 and to issue a permanent injunction preventing the enforcement of section 5.2.3 of the Agreement.
In August 2018, Beckman filed a motion for partial summary adjudication on the declaratory judgment cause of action. In its papers, Beckman stated it was developing and planning to launch a new laboratory analyzer platform and wanted to develop a competing assay product for the new platform. It argued section 5.2.3 of the Agreement was a non-compete clause that was void under Business and Professions Code section 16600.
On November 7, 2018, Quidel moved ex parte for a continuance of the motion. In the hearing, Quidel argued additional discovery was necessary to determine if there were material issues of fact in dispute. Beckman contended *536there was no need for additional discovery to determine the impact of section 16600 on the parties' Agreement. The court denied the ex parte request.
The trial court ultimately granted Beckman's motion for summary adjudication. It noted none of the statutory exceptions to the restraint on trade outlined in section 16600 apply and explained it was unpersuaded by the legal authority cited by Quidel because it predated Edwards or discussed exclusive dealing contracts in the context of franchise relationships. Relying on Edwards , the trial court concluded section 16600 voids every contract that restrains anyone from " 'engaging in a lawful profession, trade, or business of any kind ....' [Citation.]" Accordingly, it concluded section 5.2.3 of the Agreement was void because it "restrains [Beckman] from developing, marketing, or assisting others in the development and marketing of an assay that measures or detects the presence or absence of BNP or NT-proBNP."
Quidel moved to stay the order pending final appeal or pending resolution of a writ petition seeking a stay and sought an extension of time to file a writ. The court granted the request.
On January 18, 2019, Quidel filed a petition for writ of mandate and/or prohibition and sought a stay pending a determination of the writ on its merits. Beckman filed a preliminary opposition to the petition, to which Quidel replied. We issued an order to show cause why a peremptory writ should not issue and stayed the order granting Beckman's motion for summary adjudication pending further order. We deemed the preliminary opposition filed by Beckman to be its return to the order to show cause. We now turn to the merits of the petition.
DISCUSSION
A
Review on Petition for Writ Appropriate
As a preliminary matter, this case is appropriately before us as a petition for writ of mandate. Although appellate courts "seldom use extraordinary writs to review interlocutory summary adjudication orders (grants or denials)" ( Int'l Ins. Co. v. Superior Court (1998)
In the present case, the petitioner has raised a significant legal question of broad public interest: Does section 16600 invalidate all contractual noncompete provisions, even outside the employment context, without regard to the reasonableness of the restraint imposed or whether the terms actually advance, rather than restrain, competition? (See California Highway Patrol v. Superior Court (2006)
B
Standard of Review
A grant of summary adjudication is appropriate if there are no triable issues of material fact and the moving party is entitled to judgment as a matter of law. ( Code of Civ. Proc., § 437c, subd. (c) ; Aguilar v. Atlantic Richfield Co. (2001)
We review a motion for summary adjudication de novo. ( Benson v. Superior Court (2010)
Section 16600
At the heart of this dispute is the interpretation of section 16600, which provides, subject to three statutory exceptions, that "every contract by which anyone is restrained from engaging in a lawful profession, trade, or business of any kind is to that extent void." Quidel argues that in the context of an exclusive dealing business arrangement between two corporate entities, a court should consider whether an in-term noncompetition provision promotes competition or restrains it, taking into consideration a multi-factor test that contemplates the purposes, effects, or reasonableness of the provision's restraint. Beckman urges the court to deny the writ on its merits and to uphold the superior court's extension of the Supreme Court's holding in Edwards : "Noncompetition agreements are invalid under section 16600 in California, even if narrowly drawn, unless they fall within the applicable statutory exceptions of sections 16601, 16602, or 166025."
1. Covenants Not to Compete in the Employment Context
Quidel distinguishes the holding in Edwards in two ways. First, it argues the holding should not be extended beyond the employment context it decided. Second, it notes Edwards addressed postterm covenants not to compete, and Quidel argues in-term covenants should be treated differently.
In Edwards , the plaintiff signed an agreement with Arthur Andersen that prohibited him from working for or soliciting any of Arthur Andersen's clients for a period of time following his termination of employment. ( Edwards, supra , 44 Cal.4th at p. 942,
The Supreme Court agreed with Edwards. It explained: "[S]ection 16600 evinces a settled legislative policy in favor of open competition and employee mobility"; it noted people have the right to pursue lawful employment and to engage in businesses and occupations of their choice. ( Edwards, supra , 44 Cal.4th at p. 946,
However, " '[i]t is axiomatic that language in a judicial opinion is to be understood in accordance with the facts and issues before the court. An opinion is not authority for propositions not considered.' " ( *829Kinsman v. Unocal Corp. (2005)
The strict application of section 16600 in the employment context is supported by the policy: "California courts have consistently declared this provision an expression of public policy to ensure that every citizen shall retain the right to pursue any lawful employment and enterprise of their choice." ( Metro Traffic Control, Inc. v. Shadow Traffic Network (1994)
Beckman contends a panel of this court, in AMN Healthcare , concluded the rule outlined in Edwards applies "notwithstanding the different factual context or the existence of prior inconsistent authority." We disagree. AMN Healthcare addressed solicitation of individual employees by a competitor.
*540( AMN Healthcare,
Unlike noncompete clauses that attempt to dilute or eliminate employee mobility, an interest California courts have found to be a cherished commercial right ( Morlife, Inc. v. Perry (1997)
2. Covenants Not to Compete Outside the Employment Context
Although no published case law since Edwards has addressed the applicability of the presumptive rule announced therein outside the employment context, noncompetition clauses have been deemed valid outside the employment arena in case law predating Edwards. In Great Western Distillery Products, Inc. v. John A. Wathen Distillery Co. (1937)
The Supreme Court determined the purpose of the contract in Great Western was to promote business, and it concluded any incidental or indirect restrictions did not bring the contract within the statute. ( Great Western, supra , 10 Cal.2d at p. 446,
Following Great Western , courts applied a test of reasonability, contemplating whether the arrangement promoted competition. For example, in Keating v. Preston (1940)
While California courts have followed a rule of reason outside the employment context, they have also concluded, without discussion, that agreements to develop monopolies are unlawful. For example, in Vulcan Powder Co. v. Hercules Powder Co. (1892)
Thus, as long as a noncompetition provision does not negatively affect the public interests, is designed to protect the parties in their dealings, and does not attempt to establish a monopoly, it may be reasonable and valid. (See Great Western, supra , 10 Cal.2d at pp. 449-450,
3. In-Term Covenants Not to Compete
Quidel separately contends Edwards is distinguishable from the case at hand because it evaluated a postterm covenant not to compete, while in-term noncompetition clauses have been held valid. To support its position, Quidel cites Dayton Time Lock Service, Inc. v. Silent Watchman Corp. (1975)
Beckman contends Dayton Time Lock is inapplicable, and it cites Kelton v. Stravinski (2006)
Although Kelton distinguished its facts from those in Dayton Time Lock because Dayton Time Lock regarded a franchise agreement instead of an equal partnership, the Ninth Circuit noted that " Dayton Time Lock and Kelton make evident that under [ section] 16600 an in-term covenant not to compete in a franchise-like agreement will be void if it 'foreclose[s] competition in a substantial share' of business trade or market."
4. Comparing Section 16600 to the Cartwright Act
Finally, Beckman argues section 16600 cannot require evaluation of the reasonableness of the terms of a noncompetition provision because such an approach would make the Cartwright Act, which already requires a similar evaluation, superfluous. Beckman explains that under a test of reasonableness, a litigant deciding whether to allege a violation of section 16600 would have the burden of proving the unreasonableness of the restraint on trade, but would recover only declaratory relief, while a litigant alleging a violation of the Cartwright Act would carry the same burden, but success could be rewarded with treble damages in addition to a declaration of invalidity. Thus, there would be "no reason to ever invoke section 16600 to challenge an 'in-term' business restraint." We disagree.
First, the statutes can apply to different courses of action. While section 16600 prohibits restraints of "lawful profession, trade, or business of any kind," the Cartwright Act also prohibits trusts, a "combination of capital, skill or acts by two or more persons" for any of a number of enumerated purposes.
D
Application of Section 16600 to the Agreement
To prevail on its motion for summary adjudication, Beckman must demonstrate there are no triable issues of material fact that section 5.2.3 of the Agreement (1) tends to restrain trade more than promote it ( Great Western,
There is no dispute that section 5.2.3 of the Agreement limits Beckman's ability to develop a competing assay to diagnose cardiac disease. Section 5.2.3 prohibits Beckman from researching or developing an assay that detects the presence or absence of the BNP or NT-proBNP proteins or markers.
*545Quidel maintains that the BNP and NT-proBNP assays are interchangeable and that Beckman can research and develop the presence or absence of other biomarkers, like ST2 or Galectin 3, suggesting the restraint is reasonably narrow. However, whether these limitations tend to restrain trade more than promote it remains unclear and requires a factual analysis.
Additionally, whether section 5.2.3 of the Agreement is necessary to protect the parties in their dealings similarly requires a factual analysis, and the record on this issue is incomplete. Quidel argues that because the NT-proBNP assay is a direct substitute for the BNP assay, the prohibition on researching and developing an NT-proBNP assay until two years before the Agreement's conclusion is necessary to protect Quidel's interests in dealing with Beckman. However, whether prohibiting development of NT-proBNP assay is necessary to protect parties in their dealings is disputed. Beckman opted not to present evidence regarding the purpose or effect of the Agreement, instead contending such facts and evidence were immaterial to the dispute regarding application of section 16600. Finally, whether the Agreement forecloses a substantial share of the line of *834commerce has likewise not been factually developed.
In the November 7, 2018 hearing, Beckman's attorneys repeatedly conceded that the purpose of their motion for summary adjudication was to avoid engaging in detailed discovery on anti-trust issues, stating that if "full-blown anti-trust analysis" was required, the motion should be denied. Because we have concluded that the rule announced in Edwards does not extend beyond the employment context, we conclude such factual development is relevant and necessary here.
DISPOSITION
The petition for writ of mandate and/or prohibition is granted. Let a writ issue directing the trial court to vacate its December 7, 2018 order granting the motion for summary adjudication, and to enter a new order denying the motion. The stay issued by this court on March 14, 2019, is vacated.
Petitioner to recover costs.
WE CONCUR:
IRION, J.
GUERRERO, J.
Future section references are to the Business and Professions Code unless otherwise specified.
As a result of acquisitions, Quidel is the successor in interest to Biosite, and Quidel is the current counter-party to Beckman under the BNP Assay Agreement.
The parties agree none of the exceptions apply here.
Beckman contends franchise agreements are different from other exclusive dealing contracts because they are heavily regulated and necessarily contain exclusivity provisions to protect the franchisor's intellectual property due to the franchisee's substantial association with the franchisor's trademark or other mark. (See Kelton, supra , 138 Cal.App.4th at pp. 947-948,
Section 16720 provides: "A trust is a combination of capital, skill or acts by two or more persons for any of the following purposes: [¶] (a) [t]o create or carry out restrictions in trade or commerce[;] [¶] (b) [t]o limit or reduce the production, or increase the price of merchandise or of any commodity[;] [¶] (c) [t]o prevent competition in manufacturing, making, transportation, sale or purchase of merchandise, produce or any commodity[;] [¶] (d) [t]o fix at any standard or figure, whereby its price to the public or consumer shall be in any manner controlled or established, any article or commodity of merchandise, produce or commerce intended for sale, barter, use or consumption in this State[;] [¶] (e) [t]o make or enter into or execute or carry out any contracts, obligations or agreements of any kind or description, by which they do all or any or any combination of any of the following: [¶] (1) [b]ind themselves not to sell, dispose of or transport any article or any commodity or any article of trade, use, merchandise, commerce or consumption below a common standard figure, or fixed value[;] [¶] (2) [a]gree in any manner to keep the price of such article, commodity or transportation at a fixed or graduated figure[;] [¶] (3) [e]stablish or settle the price of any article, commodity or transportation between them or themselves and others, so as directly or indirectly to preclude a free and unrestricted competition among themselves, or any purchasers or consumers in the sale or transportation of any such article or commodity[;] [¶] (4) [a]gree to pool, combine or directly or indirectly unite any interests that they may have connected with the sale or transportation of any such article or commodity, that its price might in any manner be affected."
Civil Code section 1673, the predecessor statute to Business and Professions Code section 16600, was enacted in 1872. (Cianci v. Superior Court (1985)